Your browser doesn't support javascript.
loading
Host-Directed Targeting of LincRNA-MIR99AHG Suppresses Intracellular Growth of Mycobacterium tuberculosis.
Gcanga, Lorna; Tamgue, Ousman; Ozturk, Mumin; Pillay, Shandre; Jacobs, Raygaana; Chia, Julius Ebua; Mbandi, Stanley Kimbung; Davids, Malika; Dheda, Keertan; Schmeier, Sebastian; Alam, Tanvir; Roy, Sugata; Suzuki, Harukazu; Brombacher, Frank; Guler, Reto.
Afiliación
  • Gcanga L; International Centre for Genetic Engineering and Biotechnology (ICGEB), Department of Pathology, Cape Town Component, Cape Town, South Africa.
  • Tamgue O; Division of Immunology, Department of Pathology, Institute of Infectious Diseases and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
  • Ozturk M; Immunology of Infectious Diseases, Faculty of Health Sciences, South African Medical Research Council (SAMRC) University of Cape Town, Cape Town, South Africa.
  • Pillay S; International Centre for Genetic Engineering and Biotechnology (ICGEB), Department of Pathology, Cape Town Component, Cape Town, South Africa.
  • Jacobs R; Division of Immunology, Department of Pathology, Institute of Infectious Diseases and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
  • Chia JE; Immunology of Infectious Diseases, Faculty of Health Sciences, South African Medical Research Council (SAMRC) University of Cape Town, Cape Town, South Africa.
  • Mbandi SK; Department of Biochemistry, Faculty of Sciences, University of Douala, Douala, Cameroon.
  • Davids M; International Centre for Genetic Engineering and Biotechnology (ICGEB), Department of Pathology, Cape Town Component, Cape Town, South Africa.
  • Dheda K; Division of Immunology, Department of Pathology, Institute of Infectious Diseases and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
  • Schmeier S; Immunology of Infectious Diseases, Faculty of Health Sciences, South African Medical Research Council (SAMRC) University of Cape Town, Cape Town, South Africa.
  • Alam T; International Centre for Genetic Engineering and Biotechnology (ICGEB), Department of Pathology, Cape Town Component, Cape Town, South Africa.
  • Roy S; Division of Immunology, Department of Pathology, Institute of Infectious Diseases and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
  • Suzuki H; Immunology of Infectious Diseases, Faculty of Health Sciences, South African Medical Research Council (SAMRC) University of Cape Town, Cape Town, South Africa.
  • Brombacher F; International Centre for Genetic Engineering and Biotechnology (ICGEB), Department of Pathology, Cape Town Component, Cape Town, South Africa.
  • Guler R; Division of Immunology, Department of Pathology, Institute of Infectious Diseases and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
Nucleic Acid Ther ; 32(5): 421-437, 2022 10.
Article en En | MEDLINE | ID: mdl-35895506
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis / ARN Largo no Codificante / Mycobacterium tuberculosis Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nucleic Acid Ther Año: 2022 Tipo del documento: Article País de afiliación: Sudáfrica Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis / ARN Largo no Codificante / Mycobacterium tuberculosis Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nucleic Acid Ther Año: 2022 Tipo del documento: Article País de afiliación: Sudáfrica Pais de publicación: Estados Unidos